Beyond COVID-19 Spending Growth, Biosimilars Slowed Growth In Other Categories

IQVIA Finds Non-COVID Drug Spending Up Just 5%

 
• By Alaric DeArment
  
A shot directly from above of a cut dollar sign on the right with various pills arranged on the top of it on the green background - Image
IQVIA's Institute for Human Data Science released its drug spending report for 2022 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip